Free Trial

Synthomer (SYNT) Competitors

Synthomer logo
GBX 154.40 -5.60 (-3.50%)
(As of 12/20/2024 11:56 AM ET)

SYNT vs. VCT, ELM, SCPA, ESNT, TET, ZTF, IOF, WCH, ITX, and DCTA

Should you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Elementis (ELM), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.

Synthomer vs.

Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings, institutional ownership and community ranking.

Victrex currently has a consensus price target of GBX 1,425, indicating a potential upside of 34.94%. Synthomer has a consensus price target of GBX 288.33, indicating a potential upside of 86.74%. Given Synthomer's stronger consensus rating and higher possible upside, analysts plainly believe Synthomer is more favorable than Victrex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Victrex
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Synthomer
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

97.1% of Victrex shares are owned by institutional investors. Comparatively, 43.8% of Synthomer shares are owned by institutional investors. 1.6% of Victrex shares are owned by insiders. Comparatively, 28.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Victrex has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500.

Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 5.7%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 16.2%. Victrex pays out 17,142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -4,098.4% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.

Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.33%. Victrex's return on equity of 6.36% beat Synthomer's return on equity.

Company Net Margins Return on Equity Return on Assets
Victrex10.81% 6.36% 6.59%
Synthomer -4.33%-7.90%-0.28%

In the previous week, Victrex had 4 more articles in the media than Synthomer. MarketBeat recorded 4 mentions for Victrex and 0 mentions for Synthomer. Victrex's average media sentiment score of 1.47 beat Synthomer's score of 0.00 indicating that Victrex is being referred to more favorably in the media.

Company Overall Sentiment
Victrex Positive
Synthomer Neutral

Victrex has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Victrex£284.10M3.23£30.70M£0.353,017.14
Synthomer£1.97B0.13-£83.30M-£0.61-253.11

Synthomer received 219 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.49% of users gave Synthomer an outperform vote while only 63.61% of users gave Victrex an outperform vote.

CompanyUnderperformOutperform
VictrexOutperform Votes
507
63.61%
Underperform Votes
290
36.39%
SynthomerOutperform Votes
726
68.49%
Underperform Votes
334
31.51%

Summary

Victrex and Synthomer tied by winning 10 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SYNT vs. The Competition

MetricSynthomerSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£252.55M£8.59B£2.84B£1.90B
Dividend Yield28.47%3.54%5.16%5.55%
P/E Ratio-253.11301.20112.651,821.81
Price / Sales0.13482.66797,527.89386,342.76
Price / Cash2.2819.2524.3728.54
Price / Book0.225.413.402.78
Net Income-£83.30M£147.63M£154.69M£157.16M
7 Day Performance-9.81%-1.80%-2.91%-2.00%
1 Month Performance-5.85%-2.92%1.16%21.23%
1 Year Performance-15.77%-17.92%17.12%29.20%

Synthomer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYNT
Synthomer
N/AGBX 154.40
-3.5%
GBX 288.33
+86.7%
-16.3%£252.55M£1.97B-253.114,200
VCT
Victrex
2.8529 of 5 stars
GBX 1,135.06
-0.3%
GBX 1,425
+25.5%
-30.3%£987.84M£284.10M3,245.711,109Gap Down
ELM
Elementis
N/AGBX 140
+1.4%
GBX 173.33
+23.8%
+11.7%£824.77M£732.20M-3,450.001,281
SCPA
Scapa Group
N/AGBX 214.50
flat
N/AN/A£402.98M£281.80M-7.321,461
ESNT
Essentra
1.8852 of 5 stars
GBX 137.60
-2.1%
GBX 216.67
+57.5%
-19.5%£395.11M£309.70M7,980.00350News Coverage
TET
Treatt
2.2542 of 5 stars
GBX 473
+2.4%
GBX 675
+42.7%
+4.4%£287.21M£143.55M2,583.33350
ZTF
Zotefoams
N/AGBX 325.85
-1.3%
N/A-15.2%£158.36M£133.40M1,650.00549
IOF
Iofina
N/AGBX 18.50
flat
GBX 35
+89.2%
-25.5%£35.49M£51.71M1,875.0095Gap Up
WCH
Wilmcote Holdings plc (WCH.L)
N/AGBX 3
flat
N/AN/A£20.13MN/A-5.003
ITX
Itaconix
N/AGBX 137.75
+4.3%
N/A+33.9%£18.58M£6.62M-3,325.0017Gap Up
DCTA
Directa Plus
N/AGBX 7.63
-0.1%
N/A-74.4%£7.96M£9.33M-133.33187Gap Up

Related Companies and Tools


This page (LON:SYNT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners